We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Alternative Molybdenum Source Could Surmount Isotope Shortage

By MedImaging International staff writers
Posted on 03 Jan 2016
Print article
Image: A room filled with Drytec generators (Photo courtesy of GE Healthcare).
Image: A room filled with Drytec generators (Photo courtesy of GE Healthcare).
New technology for manufacturing molybdenum-99 (99Mo) without the need for a nuclear reactor could help break through the medical isotope bottleneck.

Developed by SHINE Medical Technologies (SHINE; Monona, WI, USA), the alternative production method involves bombarding a low enriched uranium (LEU) uranyl sulfate solution with fast neutrons generated by a linear accelerator at Argonne National Laboratory (ANL; Lemont, IL, USA). The LEU then breaks down into hundreds of different isotopes, including 99Mo, which consists of 6% of the fissions created during the process. The 99Mo, which has a half-life of 2.75 days, must then be separated from the other fission products before it can be transported for use.

The half life of 99Mo is long compared to that of its daughter isotope, the radioactive tracer element technetium-99m (99mTc), which is created when 99Mo spontaneously decays through the release of a beta particle from its nucleus. The 99mTc, whose half-life is just six hours, is crucial for the sodium pertechnetate tracer produced using the GE Healthcare (GE, Little Chalfont, United Kingdom) Drytec generator. GE tested the new method by preparing two 99mTc-based radiopharmaceuticals, indicating the feasibility of the production method.

“We have been confident from the beginning that molybdenum-99 produced by our process would be compatible with existing technetium-99m generators, and now we’ve proved it,” said Greg Piefer, CEO of SHINE. “This demonstration validates that the cleaner, safer technical approach we’ve been pursuing can be fully integrated into the existing supply chain. I would like to thank GE and Argonne National Laboratory for making this test possible.”

“Our customers—clinics, hospitals and imaging specialists—rely on a secure supply of technetium-99m from molybdenum-99 to make sure that they can conduct important diagnostic imaging scans their patients need,” said Jan Makela, general manager of core imaging for GE Healthcare. “We are working hard to make this key isotope readily available and cost-effective for them.”

Because of its unstable nature, 99Mo does not occur naturally and is traditionally produced using highly enriched uranium (HEU) in research reactors. 99Mo is also not produced in the United States, leaving the country to rely on isotopes from other countries. SHINE is expected to begin commercial production in 2019 using this new process, and expects to be able to produce enough 99Mo to supply two-thirds of the demand of the United States.

Related Links:

SHINE Medical Technologies
Argonne National Laboratory
GE Healthcare


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
PACS Workstation
CHILI Web Viewer
New
Portable X-Ray Unit
AJEX240H

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.